Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment
ConclusionsThis is the first study to develop a conceptual model of patients ’ experience of metastatic/recurrent pancreatic cancer and explore the content validity of the EORTC QLQ-C30/PAN26 following therapeutic advances. The EORTC QLQ-C30/PAN26 appears conceptually relevant; additional items to assess neuropathic side effects are recommended. A recall period should be s tated throughout to standardise responses.
Source: Quality of Life Research - Category: Health Management Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Gastroenterology | Health Management | Immunotherapy | Neurology | Neurosurgery | Pain | Pancreas | Pancreatic Cancer | Study